Overexpression of MDM2 in leukemic cells in previously treated patients with chronic lymphocytic leukemia.

被引：0
|
作者：
Shinn, CA
Byrd, JC
Neuberg, DS
Flinn, IW
Grever, MR
机构：
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
[2] Walter Reed Army Med Ctr, Hematol Oncol Serv, Washington, DC 20307 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2422
引用
收藏
页码：542A / 542A
页数：1
相关论文
共 50 条
  • [21] TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia
    Szymanska, Agata
    Bojarska-Junak, Agnieszka
    Drobiecki, Arkadiusz
    Tomczak, Waldemar
    Rolinski, Jacek
    Hus, Marek
    Hus, Iwona
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (01) : 55 - 65
  • [22] Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma
    Ujjani, Chaitra
    Ramzi, Pari
    Gehan, Edmund
    Wang, Hongkun
    Wang, Yiru
    Cheson, Bruce D.
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 915 - 920
  • [23] Efficacy of COVID vaccinations in patients with chronic lymphocytic leukemia.
    Annunzio, Kaitlin
    Hu, Eileen
    Huang, Ying
    Grantier, Cara
    Grever, Michael R.
    Hoffman, Corinne
    Kittai, Adam
    Lozanski, Gerard
    Lucas, Margaret
    Moran, Mollie
    Reid, Mark
    Shindiapina, Polina
    Suresh, Swetha
    Woyach, Jennifer Ann
    Bhat, Seema Ali
    Rogers, Kerry Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] 'Indolent' chronic lymphocytic leukemia. Analysis of 224 patients
    Desablens, B
    Dib, M
    Garidi, R
    Bennouna, A
    Claisse, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 436 - 436
  • [25] Novel Prognostic Markers in Previously Treated Chronic Lymphocytic Leukemia
    Pabon, Cindy M.
    Brander, Danielle M.
    Stewart, Tiffany
    Weinberg, J. Brice
    BLOOD, 2021, 138
  • [26] MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia
    Willander, Kerstin
    Ungerback, Jonas
    Karlsson, Karin
    Fredrikson, Mats
    Soderkvist, Peter
    Linderholm, Mats
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (03) : 251 - 256
  • [27] Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib
    Woyach, Jennifer A.
    Jones, Daniel
    Jurczak, Wojciech
    Robak, Tadeusz
    Illes, Arpad
    Kater, Arnon P.
    Ghia, Paolo
    Byrd, John C.
    Seymour, John F.
    Long, Susan
    Mohamed, Nehad
    Benrashid, Samon
    Lai, Tzung-Huei
    De Jesus, Gary
    Lai, Richard
    de Bruin, Gerjan
    Rule, Simon
    Munugalavadla, Veerendra
    BLOOD, 2024, 144 (10) : 1061 - 1068
  • [28] Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
    Montillo, M.
    O'Brien, S.
    Tedeschi, A.
    Byrd, J. C.
    Dearden, C.
    Gill, D.
    Brown, J. R.
    Barrientos, J. C.
    Mulligan, S. P.
    Furman, R. R.
    Cymbalista, F.
    Plascencia, C.
    Chang, S.
    Hsu, E.
    James, D. F.
    Hillmen, P.
    BLOOD CANCER JOURNAL, 2017, 7 : e524 - e524
  • [29] Pentostatin and cyclophosphamide: An effective new regimen in previously treated patients with chronic lymphocytic leukemia
    Weiss, MA
    Maslak, PG
    Jurcic, JG
    Scheinberg, DA
    Aliff, TB
    Lamanna, N
    Frankel, SR
    Kossman, SE
    Horgan, D
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1278 - 1284
  • [30] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
12345